Exogenous procalcitonin evokes a pro-inflammatory cytokine response
- 17 October 2010
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 60 (2) , 203-207
Abstract
Procalcitonin (ProCT) is increased in serum of septic patients and those with systemic inflammation. Endogenous levels of ProCT might influence the response of polymorphonuclear leukocytes (PMNs), independently of endotoxin, in clinical disease.Keywords
This publication has 20 references indexed in Scilit:
- Examination of the effect of procalcitonin on human leucocytes and the porcine isolated coronary arteryBritish Journal of Anaesthesia, 2008
- Procalcitonin has bioactivity at calcitonin receptor family complexes: Potential mediator implications in sepsis*Critical Care Medicine, 2008
- Procalcitonin assay in systemic inflammation, infection, and sepsis: Clinical utility and limitationsCritical Care Medicine, 2008
- Neutrophil chemotaxis and receptor expression in clinical septic shockIntensive Care Medicine, 2004
- Immunoneutralization of procalcitonin as therapy of sepsisInnate Immunity, 2003
- Immunoneutralization of procalcitonin as therapy of sepsisInnate Immunity, 2003
- Late Immunoneutralization of Procalcitonin Arrests the Progression of Lethal Porcine SepsisSurgical Infections, 2001
- Assessment of Neutrophil Function in Patients with Septic Shock: Comparison of MethodsClinical and Diagnostic Laboratory Immunology, 2001
- Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to SepsisThe Journal of Clinical Endocrinology & Metabolism, 2001
- Longitudinal analysis of neutrophil superoxide anion generation in patients with septic shockCritical Care Medicine, 1993